A Phase II Trial of Trastuzumab Combined with Irinotecan in Patients with Advanced HER2-positive Chemo-refractory Gastric Cancer: OGSG1203 (HERBIS-5)

Daisuke Sakai, Junji Kawada, Ryohei Kawabata, Kazuhiro Nishikawa, Tomono Kawase, Yoshio Oka, Naotoshi Sugimoto, Takeshi Shimizu, Junichi Nishijima, Hiroko Hasegawa, Shunji Endo, Yutaka Isozaki, Yutaka Kimura, Jin Matsuyama, Yukinori Kurokawa, Toshio Shimokawa, Kazumasa Fujitani, Taroh Satoh　Korean Cancer Association 2016 , Seoul, 16-17 June 2016

Warning: Trying to access array offset on false in /home/grwdev/grwdev.works/public_html/ogsg2026.grwdev.works/wp/wp-content/themes/OGSG/single.php on line 62